Shares of Astrotech Corporation (NASDAQ:ASTC – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.84 and traded as low as $7.38. Astrotech shares last traded at $7.44, with a volume of 34,634 shares changing hands.
Analyst Ratings Changes
A number of research analysts have issued reports on ASTC shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Astrotech in a report on Monday. Wall Street Zen upgraded shares of Astrotech from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 1st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.
Get Our Latest Stock Report on ASTC
Astrotech Stock Up 0.4%
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of ASTC. J. Safra Sarasin Holding AG bought a new position in Astrotech in the 1st quarter valued at $140,000. BlackRock Inc. acquired a new position in shares of Astrotech during the second quarter valued at $220,000. DRW Securities LLC boosted its holdings in Astrotech by 168.5% in the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after acquiring an additional 19,747 shares during the last quarter. Susquehanna International Group LLP bought a new stake in Astrotech during the 3rd quarter worth about $66,000. Finally, SCS Capital Management LLC bought a new position in shares of Astrotech in the 2nd quarter valued at about $120,000. Institutional investors own 24.35% of the company’s stock.
Astrotech Company Profile
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
See Also
- Five stocks we like better than Astrotech
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
- Photronics Is Quietly Becoming a Key Winner From the AI Boom
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
